Research · Systematic review
Beta-sitosterols for benign prostatic hyperplasia
What it found
Improved symptoms (IPSS −4.9) and peak urine flow (+3.9 mL/s) versus placebo, but trials were few, short, and did not assess long-term effects.
- Design
- Systematic review
- Year
- 2000
- Sample size
- 519
- Population
- men with BPH (4 placebo-controlled RCTs)
- Intervention
- beta-sitosterol preparations vs placebo
- Outcome
- urinary symptom score (IPSS), peak urine flow, residual volume
- Journal
- Cochrane Database of Systematic Reviews
Citation last checked 2026-06-21.